Breast Implantation (Implantation, Breast)

Surgical insertion of an inert sac filled with silicone or other material to augment the female form cosmetically.
Also Known As:
Implantation, Breast; Breast Implantations; Breast Prosthesis Implantations; Implantation, Breast Prosthesis; Implantations, Breast; Implantations, Breast Prosthesis; Prosthesis Implantation, Breast; Prosthesis Implantations, Breast; Breast Prosthesis Implantation
Networked: 55 relevant articles (0 outcomes, 9 trials/studies)

Therapy Context: Research Results


1. Friis, Søren: 9 articles (11/2013 - 01/2004)
2. McLaughlin, Joseph K: 8 articles (11/2011 - 01/2004)
3. Hölmich, Lisbet R: 5 articles (11/2011 - 07/2004)
4. Olsen, Jørgen H: 5 articles (01/2009 - 01/2004)
5. Fryzek, Jon P: 5 articles (05/2007 - 07/2004)
6. Kjøller, Kim: 5 articles (05/2007 - 07/2004)
7. McLaughlin, J K: 5 articles (09/2003 - 10/2000)
8. Olsen, J H: 5 articles (09/2003 - 10/2000)
9. Henriksen, Trine F: 4 articles (11/2011 - 04/2005)
10. Lipworth, Loren: 3 articles (11/2011 - 05/2007)

Related Diseases

1. Breast Neoplasms (Breast Cancer)
2. Neoplasms (Cancer)
3. Connective Tissue Diseases (Connective Tissue Disease)
4. Seroma
02/01/2012 - "A clinical study of late seroma in breast implantation surgery."
01/01/2015 - "Panelists agreed that (1) this disease should be called "BIA-ALCL"; (2) late seromas occurring >1 year after breast implantation should be evaluated via ultrasound, and if a seroma is present, the fluid should be aspirated and sent for culture, cytology, flow cytometry, and cell block to an experienced hematopathologist; (3) surgical removal of the affected implant and capsule (as completely as possible) should occur, which is sufficient to eradicate capsule-confined BIA-ALCL; (4) surveillance should consist of clinical follow-up at least every 6 months for at least 5 years and breast ultrasound yearly for at least 2 years; and (5) BIA-ALCL is generally a biologically indolent disease with a good prognosis, unless it extends beyond the capsule and/or presents as a mass. "
01/01/2009 - "Although seroma is not an uncommon complication in the immediate postoperative period, it is extremely rare as a late complication of breast implantation. "
09/01/2011 - "Panelists agreed that (1) there is a positive association between breast implants and ALCL development but likely underrecognition of the true number of cases; (2) a recurrent, clinically evident seroma occurring 6 months or more after breast implantation should be aspirated and sent for cytologic analysis; (3) anaplastic lymphoma kinase-negative ALCL that develops around breast implants is a clinically indolent disease with a favorable prognosis that is distinct from systemic anaplastic lymphoma kinase-negative ALCL; (4) management should consist of removal of the involved implant and capsule, which is likely to prevent recurrence, and evaluation for other sites of disease; and (5) adjuvant radiation or chemotherapy should not be offered to women with capsule-confined disease. "
5. Infection

Related Drugs and Biologics

1. Silicones
2. Cosmetics
3. HLA-B8 Antigen (HLA B8 Antigen)
4. Triamcinolone Acetonide (Azmacort)
5. Silicon
6. Rheumatoid Factor
7. Prolactin
8. Complement C3 (C3 Complement)
9. anaplastic lymphoma kinase

Related Therapies and Procedures

1. Breast Implants (Breast Implant)
2. Mammaplasty (Breast Reconstruction)
3. Mastectomy (Mammectomy)
4. Drug Therapy (Chemotherapy)
5. Subcutaneous Mastectomy